Clindamycin-MIP

Medicinal product

(Invented) name

Clindamycin-MIP

Active substance (s)

Klindamicinas

Strength

150 mg/ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į veną, leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01FF01, Clindamycin

Marketing authorisation holder

MIP Pharma GmbH, Vokietija

Date of authorisation

2003-03-28

Date of renewal

2012-08-10

Documents

3005 Pakuotės lapelis inj 2021 11 15.docx

3005 Clindamycin MIP inj RPP 2021 11 15.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

1 ml tirpalo yra	1 ml
Klindamicinas	150 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
7515	12459	1012459	flakonas	4 ml N5		Receptinis	LT/1/03/3005/016	Tiekiama	-	-	No	-	-
53333	67276	1067276	flakonas	6 ml N5		Receptinis	LT/1/03/3005/018	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2012-08-10	Perregistruotas
2003-03-28	Registruotas